Edwards Lifesciences Corp., EW is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Edwards Lifesciences Corp., EW has a market cap of 24617.52. Since its IPO date on the 3/27/2000, Edwards Lifesciences Corp., EW performance year to date is 46.87%. Today Edwards Lifesciences Corp., EW has gained -2.24%, with a current price of 116.
Ownership of the company is 0.30% for insider ownership while institutional ownership is 87.20%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 13.30%, with return on investment at 15.90%.
In terms of debt levels and profit levels, Edwards Lifesciences Corp., EW is seeing a long-term debt/equity of 0.24. While Total debt/equity is 0.24. With a profit margin of 19.30%, this is combined with a gross margin of 74.30%, and operating margin of 24.40%. Edwards Lifesciences Corp. ability to meet debt levels, with a current ratio of 4.2, while the quick ratio is 3.4.
For the last year Edwards Lifesciences Corp., EW has seen a EPS growth of -39.80%. A performance for the year of 57.66%. The 52-week high is -4.72%, and the 52-week low is 61.26%. The average volume for Edwards Lifesciences Corp., EW is 2013608.
With a target price of 124.9, can Edwards Lifesciences Corp., EW reach this target? Looking at the value indicators of Edwards Lifesciences Corp., EW. Edwards Lifesciences Corp. has a P/E of 47.99 and a forward P/E of 34.1. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.74. Edwards Lifesciences Corp. also has a P/S and a P/B of 8.97 and 9.96 respectively. For P/cash, Edwards Lifesciences Corp. has a value of 23.22, while it is 57.18 for P/free cash flow.
At the current price of 116, Edwards Lifesciences Corp. has a dividend yield of *TBA. We see a return on equity of 21.80%.
Looking more long-term Edwards Lifesciences Corp., is projected to get an EPS growth for the next five years of 17.50%. In the short-term an EPS growth of 18.33% in the next year is forecasted. This is after a EPS growth of -39.80% for this year and for the last five years a 19.70% growth has been seen.